Re:Alonso Garcia-Ruiz、Carlos Macarro、Francesca Zacchi 等:《全身磁共振成像作为伴有骨转移的阉割耐药前列腺癌的治疗反应生物标志物》(Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases):iPROMET 临床试验》。Eur Urol.https://doi.org/10.1016/j.eururo.2024.02.016.
A.R. Padhani, Frédéric Lecouvet, G. Petralia, Dow-Mu Koh
{"title":"Re:Alonso Garcia-Ruiz、Carlos Macarro、Francesca Zacchi 等:《全身磁共振成像作为伴有骨转移的阉割耐药前列腺癌的治疗反应生物标志物》(Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases):iPROMET 临床试验》。Eur Urol.https://doi.org/10.1016/j.eururo.2024.02.016.","authors":"A.R. Padhani, Frédéric Lecouvet, G. Petralia, Dow-Mu Koh","doi":"10.1016/j.eururo.2024.04.035","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":94000,"journal":{"name":"European urology","volume":"51 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Re: Alonso Garcia-Ruiz, Carlos Macarro, Francesca Zacchi, et al. Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.016.\",\"authors\":\"A.R. Padhani, Frédéric Lecouvet, G. Petralia, Dow-Mu Koh\",\"doi\":\"10.1016/j.eururo.2024.04.035\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":94000,\"journal\":{\"name\":\"European urology\",\"volume\":\"51 4\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European urology\",\"FirstCategoryId\":\"0\",\"ListUrlMain\":\"https://doi.org/10.1016/j.eururo.2024.04.035\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European urology","FirstCategoryId":"0","ListUrlMain":"https://doi.org/10.1016/j.eururo.2024.04.035","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Re: Alonso Garcia-Ruiz, Carlos Macarro, Francesca Zacchi, et al. Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.016.